Pharmacology Chemical Research in Toxicology
Gadolinium Contrast Agents Trigger Danger Signals in Neuronal Cells, Linear Chelate and Free Salt Included
- Neuroblastoma SH-SY5Y cells were treated with a macrocyclic chelate (gadoterate), a linear chelate (gadopentetic acid) and free GdCl3.
- The work asked whether they release danger-associated molecular patterns, a step toward immunogenic cell death, and tracked intracellular gadolinium accumulation and localisation.
- It points to an immune-activating component of gadolinium toxicity beyond direct cytotoxicity.
The comparison I care about is macrocyclic versus linear chelate versus free ion, since stability is what separates them clinically. But the exposures are in vitro on a neuroblastoma line, and I'd want to know how they relate to the brain gadolinium levels actually measured after repeated dosing before reading any clinical risk into it.
Paper: Chemical Research in Toxicology ↗ Gadolinium-Based Contrast Agents Stimulate Adaptive Immune Response through Release of DAMP Signals in Neuronal SH-SY5Y Cells